aspirin 325

Generic: aspirin

Labeler: walgreen company
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name aspirin 325
Generic Name aspirin
Labeler walgreen company
Dosage Form TABLET, DELAYED RELEASE
Routes
ORAL
Active Ingredients

aspirin 325 mg/1

Manufacturer
Walgreen Company

Identifiers & Regulatory

Product NDC 0363-0691
Product ID 0363-0691_9dcd6643-9021-4d5a-8d4a-6415e1056e1c
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 2017-07-01

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 03630691
Hyphenated Format 0363-0691

Supplemental Identifiers

RxCUI
198467
UPC
0311917193175
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin 325 (source: ndc)
Generic Name aspirin (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 325 mg/1
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 CARTON (0363-0691-12) / 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

0363-0691-12 1 BOTTLE, PLASTIC in 1 CARTON (0363-0691-12) / 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC

Ingredients (1)

aspirin (325 mg/1)

Linked Drug Pages (1)

Aspirin 325 ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "9dcd6643-9021-4d5a-8d4a-6415e1056e1c", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0311917193175"], "unii": ["R16CO5Y76E"], "rxcui": ["198467"], "spl_set_id": ["f7a5d612-443c-4701-ad3b-8eb53c87bece"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Walgreen Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (0363-0691-12)  / 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC", "package_ndc": "0363-0691-12", "marketing_start_date": "20170701"}], "brand_name": "Aspirin 325", "product_id": "0363-0691_9dcd6643-9021-4d5a-8d4a-6415e1056e1c", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "0363-0691", "generic_name": "Aspirin", "labeler_name": "Walgreen Company", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Aspirin 325", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20170701", "listing_expiration_date": "20261231"}